| Author of Study |
|
No. of patients |
|
Duration of study |
|
Active treatment |
|
Control |
|
Response* (active treatment vs. control) |
| Braun |
|
70 |
|
12 weeks |
|
Infliximab 5mg/kg |
|
Placebo |
|
BASDAI 20% improvement: 53% vs. 9% |
| Van der Heijde |
|
279 |
|
18 weeks |
|
Infliximab 5mg/kg |
|
Placebo |
|
ASAS20 response: 61% vs. 19% |
| Davis |
|
277 |
|
24 weeks |
|
Etanercept 25mg twice weekly |
|
Placebo |
|
ASAS20 response: 59% vs. 28% |
| * Comparisons were statistically significant
|